Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
Open Access
- 30 June 2022
- journal article
- research article
- Published by Elsevier in Contraception: X
- Vol. 4, 100079
Abstract
No abstract availableKeywords
Funding Information
- David and Lucile Packard Foundation (2017–65477)
This publication has 27 references indexed in Scilit:
- Twenty-Four–Month Continuation of Reversible ContraceptionObstetrics & Gynecology, 2013
- Use of modern contraception increases when more methods become available: analysis of evidence from 1982–2009Global Health: Science and Practice, 2013
- Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic reviewContraception, 2013
- Contraceptive implants: providing better choice to meet growing family planning demandGlobal Health: Science and Practice, 2013
- Continuation and Satisfaction of Reversible ContraceptionObstetrics & Gynecology, 2011
- Non-contraceptive health benefits of intrauterine hormonal systemsContraception, 2010
- User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): Data from an international surveyThe European Journal of Contraception & Reproductive Health Care, 2009
- The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptabilityTherapeutics and Clinical Risk Management, 2009
- Acceptabilité du système intra-utérin au lévonorgestrel Mirena® 52 mg après contraception orale œstroprogestativeJournal de Gynécologie Obstétrique et Biologie de la Reproduction, 2006
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006